Development and evaluation of an anti-rabies virus phosphoprotein-specific monoclonal antibody for detection of rabies neutralizing antibodies using RFFIT.

Rabies is a major public health problem with a fatality rate close to 100%; however, complete prevention can be achieved through pre- or post-exposure prophylaxis. The rapid fluorescent focus inhibition test (RFFIT) is one of the recommended testing methods to determine the production of neutralizin...

Full description

Bibliographic Details
Main Authors: Jihye Um, Byung Chul Chun, Yeong Seon Lee, Kyu Jam Hwang, Dong-Kun Yang, Jun-Sun Park, Su Yeon Kim
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-12-01
Series:PLoS Neglected Tropical Diseases
Online Access:http://europepmc.org/articles/PMC5755941?pdf=render
_version_ 1818164222433951744
author Jihye Um
Byung Chul Chun
Yeong Seon Lee
Kyu Jam Hwang
Dong-Kun Yang
Jun-Sun Park
Su Yeon Kim
author_facet Jihye Um
Byung Chul Chun
Yeong Seon Lee
Kyu Jam Hwang
Dong-Kun Yang
Jun-Sun Park
Su Yeon Kim
author_sort Jihye Um
collection DOAJ
description Rabies is a major public health problem with a fatality rate close to 100%; however, complete prevention can be achieved through pre- or post-exposure prophylaxis. The rapid fluorescent focus inhibition test (RFFIT) is one of the recommended testing methods to determine the production of neutralizing antibodies after vaccination. Here, we report the development of a new monoclonal antibody (mAb) designed to react specifically with Rabies virus (RABV) phosphoprotein (P protein), and the evaluation of its applicability to the RFFIT and its effectiveness as a diagnostic reagent for human rabies.The mAb KGH P 16B8 was produced to target the P protein of the Korean KGH RABV strain. An indirect immunofluorescence assay (IFA) was conducted to detect various strains of RABV in various cell lines. Alexa-conjugated KGH P 16B8 (16B8-Alexa) was developed for the RFFIT. The IFA test could detect RABV up to a 1:2,500 dilution, with a detection limit comparable to that of a commercial diagnostic reagent. The sensitivity, specificity, positive predictive value, and negative predictive value of the RFFIT using 16B8-Alexa in 414 clinical specimens were 98.67%, 99.47%, 99.55%, and 98.42%, respectively. The results of the RFFIT with 16B8-Alexa were strongly correlated with those obtained using an existing commercial diagnostic reagent (r = 0.995, p<0.001).The mAb developed in this study shows high sensitivity and specificity, confirming its clinical utility with the RFFIT to measure the rabies neutralizing antibody titer and establish a diagnosis in human. Thus, 16B8-Alexa is expected to serve as an alternative diagnostic reagent that is widely accessible, with potentially broad applications beyond those of the RFFIT in Korea. Further studies with 16B8-Alexa should provide insight into the immunological mechanism of the P protein of Korean RABV.
first_indexed 2024-12-11T17:02:01Z
format Article
id doaj.art-93703f715cf8443f8a09d88ec148878e
institution Directory Open Access Journal
issn 1935-2727
1935-2735
language English
last_indexed 2024-12-11T17:02:01Z
publishDate 2017-12-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Neglected Tropical Diseases
spelling doaj.art-93703f715cf8443f8a09d88ec148878e2022-12-22T00:57:47ZengPublic Library of Science (PLoS)PLoS Neglected Tropical Diseases1935-27271935-27352017-12-011112e000608410.1371/journal.pntd.0006084Development and evaluation of an anti-rabies virus phosphoprotein-specific monoclonal antibody for detection of rabies neutralizing antibodies using RFFIT.Jihye UmByung Chul ChunYeong Seon LeeKyu Jam HwangDong-Kun YangJun-Sun ParkSu Yeon KimRabies is a major public health problem with a fatality rate close to 100%; however, complete prevention can be achieved through pre- or post-exposure prophylaxis. The rapid fluorescent focus inhibition test (RFFIT) is one of the recommended testing methods to determine the production of neutralizing antibodies after vaccination. Here, we report the development of a new monoclonal antibody (mAb) designed to react specifically with Rabies virus (RABV) phosphoprotein (P protein), and the evaluation of its applicability to the RFFIT and its effectiveness as a diagnostic reagent for human rabies.The mAb KGH P 16B8 was produced to target the P protein of the Korean KGH RABV strain. An indirect immunofluorescence assay (IFA) was conducted to detect various strains of RABV in various cell lines. Alexa-conjugated KGH P 16B8 (16B8-Alexa) was developed for the RFFIT. The IFA test could detect RABV up to a 1:2,500 dilution, with a detection limit comparable to that of a commercial diagnostic reagent. The sensitivity, specificity, positive predictive value, and negative predictive value of the RFFIT using 16B8-Alexa in 414 clinical specimens were 98.67%, 99.47%, 99.55%, and 98.42%, respectively. The results of the RFFIT with 16B8-Alexa were strongly correlated with those obtained using an existing commercial diagnostic reagent (r = 0.995, p<0.001).The mAb developed in this study shows high sensitivity and specificity, confirming its clinical utility with the RFFIT to measure the rabies neutralizing antibody titer and establish a diagnosis in human. Thus, 16B8-Alexa is expected to serve as an alternative diagnostic reagent that is widely accessible, with potentially broad applications beyond those of the RFFIT in Korea. Further studies with 16B8-Alexa should provide insight into the immunological mechanism of the P protein of Korean RABV.http://europepmc.org/articles/PMC5755941?pdf=render
spellingShingle Jihye Um
Byung Chul Chun
Yeong Seon Lee
Kyu Jam Hwang
Dong-Kun Yang
Jun-Sun Park
Su Yeon Kim
Development and evaluation of an anti-rabies virus phosphoprotein-specific monoclonal antibody for detection of rabies neutralizing antibodies using RFFIT.
PLoS Neglected Tropical Diseases
title Development and evaluation of an anti-rabies virus phosphoprotein-specific monoclonal antibody for detection of rabies neutralizing antibodies using RFFIT.
title_full Development and evaluation of an anti-rabies virus phosphoprotein-specific monoclonal antibody for detection of rabies neutralizing antibodies using RFFIT.
title_fullStr Development and evaluation of an anti-rabies virus phosphoprotein-specific monoclonal antibody for detection of rabies neutralizing antibodies using RFFIT.
title_full_unstemmed Development and evaluation of an anti-rabies virus phosphoprotein-specific monoclonal antibody for detection of rabies neutralizing antibodies using RFFIT.
title_short Development and evaluation of an anti-rabies virus phosphoprotein-specific monoclonal antibody for detection of rabies neutralizing antibodies using RFFIT.
title_sort development and evaluation of an anti rabies virus phosphoprotein specific monoclonal antibody for detection of rabies neutralizing antibodies using rffit
url http://europepmc.org/articles/PMC5755941?pdf=render
work_keys_str_mv AT jihyeum developmentandevaluationofanantirabiesvirusphosphoproteinspecificmonoclonalantibodyfordetectionofrabiesneutralizingantibodiesusingrffit
AT byungchulchun developmentandevaluationofanantirabiesvirusphosphoproteinspecificmonoclonalantibodyfordetectionofrabiesneutralizingantibodiesusingrffit
AT yeongseonlee developmentandevaluationofanantirabiesvirusphosphoproteinspecificmonoclonalantibodyfordetectionofrabiesneutralizingantibodiesusingrffit
AT kyujamhwang developmentandevaluationofanantirabiesvirusphosphoproteinspecificmonoclonalantibodyfordetectionofrabiesneutralizingantibodiesusingrffit
AT dongkunyang developmentandevaluationofanantirabiesvirusphosphoproteinspecificmonoclonalantibodyfordetectionofrabiesneutralizingantibodiesusingrffit
AT junsunpark developmentandevaluationofanantirabiesvirusphosphoproteinspecificmonoclonalantibodyfordetectionofrabiesneutralizingantibodiesusingrffit
AT suyeonkim developmentandevaluationofanantirabiesvirusphosphoproteinspecificmonoclonalantibodyfordetectionofrabiesneutralizingantibodiesusingrffit